Genital Diseases, Female  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genital Diseases, Female
NCT02432365: Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

Recruiting
2
64
RoW
paclitaxel, Taxol, cisplatin, Kemoplat, Radical hysterectomy and bilateral pelvic lymphadenectomy, RH-PLND
Chang Gung Memorial Hospital, Asian Gynecologic Oncology Group, Taiwanese Gynecologic Oncology Group
Cervical Cancer
12/23
12/23
NCT02487693: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Active, not recruiting
2
50
RoW
Radiofrequency ablation, RFA, Cytokine-induced killer cells, CIK
The First People's Hospital of Changzhou
Ovarian Carcinoma
06/38
06/40
DEPICT, NCT01793701: Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer

Active, not recruiting
1/2
22
Europe
intensity modulated radiotherapy, IMRT, Intracavitary brachytherapy, Cisplatin
Queen Mary University of London, Barts & The London NHS Trust, Barts Cancer Institute
Locally Advanced Cervical Cancer
04/16
04/18

Download Options